Iovance Biotherapeutics Inc (IOVA)
8.88
-0.12
(-1.33%)
USD |
NASDAQ |
May 31, 16:00
8.89
+0.01
(+0.11%)
After-Hours: 20:00
Iovance Biotherapeutics Cash from Investing (Quarterly): -111.51M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -111.51M |
| December 31, 2023 | -72.84M |
| September 30, 2023 | -79.01M |
| June 30, 2023 | -156.78M |
| March 31, 2023 | 153.40M |
| December 31, 2022 | 0.461M |
| September 30, 2022 | 73.72M |
| June 30, 2022 | 95.76M |
| March 31, 2022 | 86.52M |
| December 31, 2021 | 69.34M |
| September 30, 2021 | 12.75M |
| June 30, 2021 | -159.16M |
| March 31, 2021 | 77.21M |
| December 31, 2020 | 58.75M |
| September 30, 2020 | -52.96M |
| June 30, 2020 | -423.76M |
| March 31, 2020 | 100.10M |
| December 31, 2019 | 26.81M |
| September 30, 2019 | 3.495M |
| June 30, 2019 | 58.68M |
| March 31, 2019 | 1.033M |
| December 31, 2018 | -206.38M |
| September 30, 2018 | -149.37M |
| June 30, 2018 | -30.50M |
| March 31, 2018 | -0.022M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.058M |
| September 30, 2017 | 14.49M |
| June 30, 2017 | 25.33M |
| March 31, 2017 | 18.80M |
| December 31, 2016 | 25.76M |
| September 30, 2016 | -16.36M |
| June 30, 2016 | -10.40M |
| March 31, 2016 | 9.88M |
| December 31, 2015 | 9.12M |
| September 30, 2015 | 20.35M |
| June 30, 2015 | -99.90M |
| March 31, 2015 | -0.782M |
| December 31, 2014 | -1.425M |
| September 30, 2014 | -0.1613M |
| June 30, 2014 | -0.0023M |
| March 31, 2014 | -0.0034M |
| December 31, 2013 | -0.0003M |
| September 30, 2013 | -0.0127M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | -0.0607M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-423.76M
Minimum
Jun 2020
153.40M
Maximum
Mar 2023
-11.95M
Average
19.78M
Median
Cash from Investing (Quarterly) Benchmarks
| Viatris Inc | -154.30M |
| Beam Therapeutics Inc | -53.46M |
| Revolution Medicines Inc | -247.97M |
| Day One Biopharmaceuticals Inc | 89.29M |
| Viking Therapeutics Inc | -459.79M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -122.28M |
| Cash from Financing (Quarterly) | 193.58M |
| Free Cash Flow | -405.08M |
| Free Cash Flow Per Share (Quarterly) | -0.475 |
| Free Cash Flow to Equity (Quarterly) | -126.45M |
| Free Cash Flow to Firm (Quarterly) | -126.45M |
| Free Cash Flow Yield | -18.38% |